ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 278

$511K Total Retail Price of All Prescriptions

Rank: 106 out of 278

345 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,415 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LISINOPRIL 612 571 1 5
LEVOTHYROXINE SODIUM 558 486 2 2
OMEPRAZOLE 517 453 3 3
AMLODIPINE BESYLATE 455 425 4 7
SIMVASTATIN 432 396 5 4
PRAVASTATIN SODIUM 400 380 6 16
FUROSEMIDE 395 341 7 6
METOPROLOL TARTRATE 325 312 8 9
FENOFIBRATE 245 194 9 64
CITALOPRAM HBR 235 199 10 21
METFORMIN HCL 218 208 11 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 216 202 12 31
GLIMEPIRIDE 216 208 12 28
METOPROLOL SUCCINATE 204 184 14 10
HYDROCHLOROTHIAZIDE 202 190 15 15
LOSARTAN POTASSIUM 200 187 16 24
ATORVASTATIN CALCIUM 176 145 17 13
LOVASTATIN 173 159 18 52
WARFARIN SODIUM 172 156 19 11
ATENOLOL 158 146 20 18
POTASSIUM CHLORIDE 158 140 20 17
TRAMADOL HCL 150 135 22 22
HYDROCODONE-ACETAMINOPHEN 144 120 S3 23 1
ENALAPRIL MALEATE 135 116 24 70
INSULIN SYRINGE 134 132 25 72
RANITIDINE HCL 133 120 26 27
ALENDRONATE SODIUM 133 133 26 51
FLUTICASONE PROPIONATE 132 103 28 44
DIGOXIN 125 122 29 40
KLOR-CON M20 124 98 30 42
CARVEDILOL 122 122 31 23
PREDNISONE 121 111 32 35
KLOR-CON 10 104 97 33 147
GABAPENTIN 104 86 33 12
DONEPEZIL HCL 103 103 35 29
TRAZODONE HCL 100 85 36 47
TERAZOSIN HCL 96 72 37 151
MELOXICAM 91 65 38 37
METFORMIN HCL ER 83 56 39 76
ALLOPURINOL 82 79 40 38
CRESTOR 80 67 41 19
VERAPAMIL ER 75 62 42 120
CLOPIDOGREL 71 71 43 20
CLONIDINE HCL 71 53 43 50
ISOSORBIDE MONONITRATE ER 69 57 45 33
TAMSULOSIN HCL 68 68 46 32
DIOVAN 66 66 47 43
PROAIR HFA 64 54 48 34
FELODIPINE ER 62 62 49 112
LEVOFLOXACIN 62 57 49 66
ROPINIROLE HCL 62 59 49 69
PLAVIX 58 58 52 30
OXYBUTYNIN CHLORIDE ER 58 58 52 146
ACETAMINOPHEN-CODEINE 55 52 S3 54 144
SPIRIVA 54 40 55 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.